N-(3-(((2-amino-9H-purin-6-yl)oxy)methyl)benzyl)-3-((6-chloro-2-methoxyacridin-9-yl)amino)propanamide

ID: ALA5200059

Chembl Id: CHEMBL5200059

PubChem CID: 168290522

Max Phase: Preclinical

Molecular Formula: C30H27ClN8O3

Molecular Weight: 583.05

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc2nc3cc(Cl)ccc3c(NCCC(=O)NCc3cccc(COc4nc(N)nc5[nH]cnc45)c3)c2c1

Standard InChI:  InChI=1S/C30H27ClN8O3/c1-41-20-6-8-23-22(13-20)26(21-7-5-19(31)12-24(21)37-23)33-10-9-25(40)34-14-17-3-2-4-18(11-17)15-42-29-27-28(36-16-35-27)38-30(32)39-29/h2-8,11-13,16H,9-10,14-15H2,1H3,(H,33,37)(H,34,40)(H3,32,35,36,38,39)

Standard InChI Key:  JUHOVAHJTCSLRW-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5200059

    ---

Associated Targets(Human)

MGMT Tchem 6-O-methylguanine-DNA methyltransferase (451 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
T98G (1524 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Calf thymus DNA (4845 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 583.05Molecular Weight (Monoisotopic): 582.1895AlogP: 5.00#Rotatable Bonds: 10
Polar Surface Area: 152.96Molecular Species: ACIDHBA: 9HBD: 4
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 6.47CX Basic pKa: 8.39CX LogP: 3.66CX LogD: 3.05
Aromatic Rings: 6Heavy Atoms: 42QED Weighted: 0.16Np Likeness Score: -1.00

References

1. Franco Pinto J, Fillion A, Duchambon P, Bombard S, Granzhan A..  (2022)  Acridine-O6-benzylguanine hybrids: Synthesis, DNA binding, MGMT inhibition and antiproliferative activity.,  227  [PMID:34731767] [10.1016/j.ejmech.2021.113909]

Source